Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 8481-8490 Newer>

Chemistry World December 4, 2012 Andrew Turley	Drug R&D costs rising Inventing a new drug costs an enormous amount of money. It's part of the reason why the pharma industry is struggling to fill its pipelines. But we'd like to think that -- however slowly -- that cost is coming down. Unfortunately it isn't.
Chemistry World December 3, 2012 Ned Stafford	Tragic death of Oxford astrophysicist Neuropsychiatric disorders have been linked to mefloquine, which was developed in the 1970s as a synthetic analogue of quinine at the US Walter Reed Army Institute of Research and later manufactured by Roche under the trade name Lariam.
Chemistry World November 30, 2012 Andy Extance	Chemists cull compounds using 'intuition' Medicinal chemists might be using far fewer parameters to choose candidate fragments for a screening collection than they think they do. Their choices can be mimicked based on just one or two properties, a team led by researchers at Swiss-headquarted pharmaceutical firm Novartis has found.
Chemistry World November 28, 2012 Andrew Turley	GSK expands in India and Nigeria GlaxoSmithKline is to spend 650 million pounds dramatically increasing its ownership of Indian and Nigerian subsidiaries.
Chemistry World November 27, 2012 Andrew Turley	Roche and the Tamiflu data The Swiss pharma company has agreed to talk to external groups about full access to data for antiviral Tamiflu (oseltamivir) tablets, according to a letter published by the British Medical Journal.
Chemistry World November 27, 2012 Derek Lowe	Full disclosure? I've been meaning to comment on all the recent calls for the drug industry to be more open with its clinical trial data. But it's hard for me to come up with anything more than 'I think it's a good idea!'
Chemistry World November 23, 2012 Andrew Turley	Schiff seals deal with Reckitt The billion-dollar tussle between German healthcare giant Bayer and UK consumer products firm Reckitt Benckiser over Schiff Nutrition has been resolved with Reckitt winning out.
Chemistry World November 23, 2012 Andrew Turley	Record insider trading case hits pharma US authorities claim that in 2008 Mathew Martoma, a hedge fund manager, was able to avoid losses of $194 million and make gains of $82 million in response to confidential clinical trial data.
Chemistry World November 22, 2012 Andrew Turley	BASF bids 664 million euros for omega-3 company Pronova makes active pharmaceutical ingredients based on omega-3 fatty acids that are used to treat cardiovascular conditions. It also makes dietary supplements.
HBS Working Knowledge November 21, 2012 Paul Guttry	What Health Care Managers Need to Know -- and How to Teach Them The educational programs for future health care leaders fail to provide many of the needed skills, according to a survey of CEOs of the world's most innovative health care firms conducted by Harvard Business School Professor Regina Herzlinger.
<Older 8481-8490 Newer> Return to current articles.